TURNOVER (x1000 NOK)
NET PROFIT (x1000 NOK)
EMPLOYEES
Pharmaxim AB
Closing information (x1000 NOK)
Closing information | 2023/12 | 2022/12 | 2021/12 |
Turnover |
176,773
|
145,003
|
178,041 |
Financial expenses |
927
|
396
|
211 |
Earnings before taxes |
11,811
|
8,824
|
8,108 |
EBITDA |
13,143
|
9,321
|
9,016 |
Total assets |
91,980
|
86,670
|
85,360 |
Current assets |
60,713
|
60,106
|
57,252 |
Current liabilities |
28,689
|
45,067
|
38,811 |
Equity capital |
45,458
|
38,906
|
42,957 |
- share capital |
1,165
|
1,088
|
1,122 |
Employees (average) |
14
|
15
|
16 |
Financial ratios
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Solvency |
49.4%
|
44.9%
|
50.3% |
Turnover per employee |
12,627
|
9,667
|
11,128 |
Profit as a percentage of turnover |
6.7%
|
6.1%
|
4.6% |
Return on assets (ROA) |
13.8%
|
10.6%
|
9.7% |
Current ratio |
211.6%
|
133.4%
|
147.5% |
Return on equity (ROE) |
26.0%
|
22.7%
|
18.9% |
Change turnover |
21,481
|
-27,688
|
-19,888 |
Change turnover % |
14%
|
-16%
|
-10% |
Chg. No. of employees |
-1
![]() |
-1
|
-4 |
Chg. No. of employees % |
-7%
|
-6%
|
-20% |
Total value of public sale
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Total value of public sale |
0
![]() |
0
![]() |
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.